Dr. Vikas P. Sukhatme
Vikas P. Sukhatme has been named chief academic officer of Beth Israel
Deaconess Medical Center (BIDMC), the medical center announced last
week. He succeeds Dr. Jeffrey S. Flier, who became dean of Harvard
Medical School last September.
A widely respected
physician-scientist in the fields of vascular biology, cancer and
kidney disease, Sukhatme joined the former Beth Israel Hospital in
1992. As chief academic officer, he will oversee BIDMC’s research and
academic programs, which include more than 850 active sponsored
projects and total more than $200 million annually.
A graduate of the Massachusetts Institute of Technology holding both a
bachelor’s and a Ph.D. in theoretical physics, Sukhatme attended the
Harvard MIT Program in Health Sciences and Technology before graduating
cum laude from Harvard Medical School in 1979. Following clinical
training at Massachusetts General Hospital, he was awarded an
immunology fellowship at Stanford University and was a Howard Hughes
investigator at the University of Chicago before joining BIDMC. He is
currently the Victor J. Aresty Professor of Medicine at Harvard Medical
Flier called Sukhatme “one of the most ‘outside-of-the-box’ thinkers
that I have known,” saying that he has “the uncanny ability to see
connections in different areas of scientific endeavor.”
Sukhatme’s research has resulted in major advances in our understanding
of numerous blood vessel disorders. The author of more than 160 papers,
his current primary area of investigation is the study of cancer
therapies focusing on the metabolism of tumor cells.
“I am deeply privileged and honored to be asked to oversee research and
education at an institution that is very dear to me,” he said.